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GENERAL INTRODUCTION 
The effect of environmental changes on phenotyplc alteration of 
bacterial characteristics has been widely observed (1,2,3). For exaiq)le, 
changes in growth conditions in vitro including temperature, pH, salts, 
carbohydrate, and protein are known to influence such things as sporula­
tion (4,5), capsulation (4,6), and the production of enzymes (4,7) and 
toxins (8-10). Similarly, organisms grown in a host often have charac­
teristics that are different from that seen when the same organism is 
grown on laboratory media (11,12). Changes in colonial morphology (12,13), 
virulence (12,14), and antigenic composition (15) can be observed when a 
recently isolated organism is repeatedly subcultured on laboratory media. 
The host environment apparently influences the surface virulence determi­
nants of bacteria. These environmentally induced modifications of 
antigens have been called antigenic modulation (4,6,16). 
To determine the bacterial and host factors Involved in pathogenicity, 
it is logical to use bacteria derived from, or grown in, the native state 
under disease conditions. This would insure the presence of aggressins, 
toxins, or virulence antigens on the bacteria involved in the infection. 
Growing organisms within the host to produce these determinants of patho­
genicity has been examined by a number of investigators (Table 1). Highly 
pathogenic bacteria which produce a massive bacteremia can be grown in 
the host directly and harvested from a specific organ or tissue just before 
death. Research on developing the techniques for the mass production of 
bacteria grown in vivo for pathogenicity studies and studies on the 
2 
Table 1. Methods of cultivation of extracellular bacteria in a host 
Septicemic bacteria - Experimentally induced septicemia (17,18,19). 
Nonsepticemic bacteria - Experimentally infected Implanted chambers. 
Subcutaneous chambers 
Steel springs (20) 
Vinyl and PVC rings (21) 
Plastic golf balls (22) 
Perforated plastic centrifuge tubes (23,24) 
Intraperitoneal chambers 
Collodion sacs (25-28) 
Cellophane dialysis tubing (29,30) 
Sealed membrane filter chambers (20,31) 
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Isolation of bacterial products were done by Smith et al. (17). This 
group was the first to develop the methodology for the cultivation and 
separation of in vivo bacteria so that chemical extraction of organisms 
to isolate virulence components and toxins could be performed (17). 
Bacillus anthracis, which produces a massive bacteremia in guinea pigs, 
was the original model (17). Later work included Yersina pestis (32-34), 
Brucella abortus (12), and to a lesser extent Streptococcus pyogenes, 
pneumoniae, Listeria monocytogenes. and Staphylococcus! aureus (17). 
Bacteria that grow in localized areas or do not multiply to signifi­
cant numbers can be used for vivo studies by growing them in implanted 
chambers (Table 1). These chambers can be implanted underneath the skin 
or deeper into the peritoneal cavity. Examples of subcutaneous implants, 
to create these chambers, include steel springs (20), vinyl rings (21), 
PVC rings (21), plastic golf practice balls (22), and perforated plastic 
centrifuge tubes (23,24). These implants become encapsulated with fibrin 
and granulation tissue producing a fluid-filled cavity providing ideal 
conditions for bacterial cultivation in a susceptible host. Chambers 
implanted intraperitoneally have been constructed from collodion sacs 
(25-28), cellophane dialysis tubing (29,30), and membrane filters (21,31). 
Pasteurella multocida isolated from a host has characteristics that 
are different from 2- multocida grown on laboratory media (19,35). 
Heddleston reported that bacterins prepared from ]P. multocida grown on 
laboratory media from one serotype did not induce cross-immunity in 
turkeys when challenged with a different immunologic type (36). Heddleston 
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then reported that vaccinated turkeys surviving homologous challenge were 
immune when re-exposed to a different immunogenic type (35). This observa­
tion revealed that the immune response in turkeys to live P. multocida was 
different from the response to laboratory grown 2» multocida. Later 
vaccines, prepared from infected turkey liver, produced immunity to 
heterologous serotypes of 2* multocida (37). Variations In these tissue 
vaccines, such as using the homogenized liver supernatant or inoculated, 
embryonated turkey egg extracts would also cross-protect (38). However, 
organisms grown dji vitro in turkey tissue enriched media or defibrinated 
turkey blood did not (38). 
Fowl cholera is generally a septicemic disease which goes through a 
bacteremic stage before death. During this time, large numbers of 
organisms can be observed in the blood. Using the techniques described 
by Smith et al. (17), Rimler et al. (19) developed methods to cultivate, 
harvest, and separate 2» multocida from infected turkey blood in sufficient 
quantity for bacteriologic studies. Pasteurella multocida was harvested 
from bacteremic blood of infected turkeys and separated from the host 
tissue by a series of differential and density gradient centrifugations.^  
Compared to 2» multocida grown on laboratory media, turkey-grown cells 
showed an increased sensitivity to physical treatment (i.e. freeze-thaw) 
that resulted in partial bacteriolysis^  (19). This lysis made studies on 
mildly disrupted bacterial preparations possible and a lytic procedure was 
R^imler RB, Rhoades KR: Lysates of turkey-grown Pasteurella 
multocida; Protection against homologous and heterologous serotype 
exposure. Am J Vet Res (in press). 
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developed to completely lyse the cells. These lysates still contained 
the Immunogen that provided protection against heterologous serotype. 
This dissertation is a segment of work started by Dr. R. B. Rimler 
to develop a cross-protective bacterin for the prevention of fowl cholera 
in turkeys. The purpose of this dissertation research was: 1. to 
examine the ultrastructure of turkey-grown 2- multocida before and after 
sequential lytic treatments in an effort to explain the peculiar nature 
of some previously reported vaccine preparations (19), 2. to define some 
of the physical properties of the cross-protection factor from lysates of 
turkey-grown multocida, and 3. to obtain a completely soluble solution 
from the disrupted, enzymatic lysate containing the cross-protection 
factor which is equal in immunizing capacity to the unlysed bacteral 
suspensions. 
The dissertation consists of 3 sections representing papers submitted 
for publication to the American Journal of Veterinary Research. Each 
section, as well as the introduction, has been prepared using the format 
of this journal. These papers represent original research involving the 
sequential steps used to obtain a solution containing CPF from turkey-
grown Pasteurella multocida lysates. 
6 
SECTION I. LYSATES OF TURKEY-GROWN PASTEURELLA MULTOCIDA; 
EXAMINATION OF VACCINE PREPARATIONS BY ELECTRON MICROSCOPY 
7 
INTRODUCTION 
In vivo propagated Pasteurella multoclda. when separated from the 
blood of Infected turkeys, can Induce protection against both homologous 
and heterologous serotypes (1). Turkey-grown P. multoclda, in contrast 
to P. multoclda grown vitro, show an increased sensitivity to freezing 
and thawing that results in partial lysis. Cross-protection factor(s) 
(CPF) that are present in freeze-thawed lysates were eliminated after 
filtration with 0.22 um filters (1). When turkey-grown multoclda 
cell suspensions were completely lysed by freeze-thaw and enzymatic 
treatment, CPF activity was maintained and became filterable^  (2). 
This electron microscopic study was done to examine the ultrastructure 
of turkey grown JP. multoclda before and after sequential treatments 
designed to release CPF in a soluble form. It was anticipated that the 
degree of solubilization and peculiar nature of some previously reported 
vaccine preparations (1) could be explained by a visual analysis. Also, 
that the host environment might influence the morphological structure of 
the organism when grown iji vivo because the host environment can influence 
the presence or absence of CPF, 
R^lmler RB, Bhoades KR: Lysates of turkey-grown Pasteurella 
multoclda ; Protection against homologous and hetero^ -ogous serotype 
challenge exposure. Am J Vet Res (in press). 
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MATERIALS AND METHODS 
Bacterial strain. Pasteurella multocida strain P-1059 iridescent 
(serotype 3) used in this study was the same strain as that used by 
Rimler and Rhoades.^  
Samples for electron microscopy. Bacteremic turkey blood was 
collected as described by Rimler et al. (1). £. multocida was separated 
from the blood by differential and density gradient centrifugation and 
frozen at -70°C.^  
Samples for examination of the effects of centrifugation on the 
turkey-grown %. multocida were taken from the 60 x g centrifugation 
supemate (S^ ), the 10,000 x g centrifugation pellet (P^ ), and the 20% 
sucrose gradient after the density centrifugation as described.^  
Methods of freezing, thawing, and enzyme treatment of turkey-grown 
2" multocida to prepare vaccines are described.^  To analyze the effect 
of the treatments on the Pasteurellae, samples were taken after treatment 
before addition of formalin. Samples were: whole cells resuspended in 
saline (Vaccine I); sucrose suspended cells that were frozen and thawed 
(Vaccine II); sucrose suspended cells that were frozen and thawed and 
treated with lytic solution (LS) containing 0.002 M EDTA, 60 ug/ml egg-
white lysozyme, 0.2% (v/v) Triton X-100, and 200 ug/ml hyaluronidase in 
0.05 M Tris buffer, pH 7.0; and sucrose suspended cells that were frozen 
and thawed, treated with LS and viscosity reducing solution (VRS) 
R^imler RB, Rhoades KR: Lysates of turkey-grown Pasteurella 
multocida; Protection against homologous and heterologous serotype 
challenge exposure. Am J Vet Res (in press). 
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(Vaccine IV) containing 0.005 M MgCl^ , 50 ug/inl DNAse I, and 200 ug/ml 
hyaluronidase in 0.05 M Tris buffer, pH 7.0. 
Thin sections. Samples were fixed in 2.5% gluteraldehyde in sodium 
cacodylate buffer (pH 7.4) for 1 hr at 4°C. Fixed whole cell suspensions 
([labelled S^ , P^ , and 20% sucrose gradient) were centrifuged to pellet 
he cells. 
Fixed cell suspension used for vaccine I, freeze-thawed, LS, and 
VRS treated material were centrifuged at 59,300 x g to pellet intact 
cells, ghost cells, cell envelope, and membrane fragments, if any. 
The pellets were washed twice in sodium cacodylate buffer and 
stained in 1.0% OsO^  for 1 hr. The pellets were again washed in sodium 
cacodylate buffer and dehydrated by a series of graded ethanol solutions. 
The dehydrated pellets were cleared in propylene oxide, infiltrated, and 
embedded in Epon 812. 
Thin sections were stained with lead citrate and uranyl acetate. 
Specimens were examined with a Phillips EM-200 electron microscope using 
double condenser illumination. Magnifications were calibrated from 
prints enlarged from the negatives by measuring standard sized latex 
spheres. 
Negative staining. Samples, duplicate to those used for thin 
sections, were negative stained with neutralized phosphotungstlc acid as 
described by Brenner and Home (2). Samples were applied to carbon-
coated, parlodion-filmed 200 mesh grids with an all-glass nebulizer. 
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RESULTS 
Rymmination of the effects of centrlfugatlon. Bacillary-shaped 
rods (0.5-0.7 x 0.9-1.3 urn), in various stages of division, were observed 
in fixed preparations of jP. multocida from the plasma (S^ ) and the 
bacterial pellet (P^ ) of the differential centrifugation, and from the 
20% sucrose gradient after the density gradieijit centrifugation. Essen­
tially no morphologic differences could be seim in thin sections of 
those preparations. The contoured, rugated, outer surface of the cells 
in negative-stained preparations (Figure lA) appeared as a loose fitting 
membranous envelope in thin section preparations (Figure IB). This 
envelope consisted of 3 layers, shown in Figure lA; a trilaminar outer 
membrane (CM), a closely associated dense intermediate layer, and an 
electron transparent interspace (IS). Next to the IS is the cytoplasmic 
membrane (CM). 
Large amounts of membranous material, blebs, were observed on the 
surface of negative-stained preparations of bacteria centrifuged from 
the plasma and resuspended in saline (vaccine I). These blebs (Figure 
IB) originated from the outer envelope. Blebs were not evident in thin 
sections of cells from the same preparation. 
Isolated areas of long, branched, fibrinous material (thought to be 
turkey plasma fibrin) were observed in the thin section preparations of 
vaccine I (Figure 2A). 
A large number of cells in this preparation had internal areas that 
appeared empty (Figure 2A) while other cells possessed internal polar 
Figure 1. Electron micrographs of turkey-grown Pasteurella 
multocida. A. A negative stained cell showing release of membranous 
material. B. Thin section preparation showing the outer membrane (ON), 
interspace (IS), and cytoplasmic membrane (CM). The bar represents 
0.5 um. 

Figure 2. Thin section preparations of turkey-grown P. multocida 
showing: A. Masses of turkey plasma fibrin (F) and empty areas within 
the cell (arrow); B and C. Empty areas (E) and polar electron dense 
areas (D); and D. Internal membranous structures associated with the 
nuclear region of the cell. The bar represents 0.5 um (A and B) and 0.1 
um C.C and D). 
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areas that were electron dense (Figures 2B and 2C). The enq)ty areas 
were not bound by membrane nor did they appear artlfactural. These 
areas varied In size from 0.11 to 0.35 urn. Similar to the ençty areas, 
the electron dense areas did not appear to be membrane bound. These 
areas, ranging from 0.14 to 0.26 um, generally appeared at the end of a 
cell. Internal membranous structures associated with the nuclear region 
of the cells were also seen (Figure 2D). These structures were centrally 
located and were uniform in size, being about 0.14 um in diameter. 
Longitudinal and transverse sections suggested that the empty areas, 
electron dense areas, and membranous structures were spherically or 
oblong shaped. 
Examination of freeze-thaw and enzyme treatments. Bacteria in 
different phases of degradation were seen in sections of the pellet from 
the freeze-thawed saiiq}le (vaccine II). As shown in Figure 3A, potentially 
viable cells (intact membranes and dense intracellular appearance), dead 
cells (flocculated intracellular material), ghost cells, and membrane 
fragments were seen. Masses of homogenous material believed to be 
flocculated protein from dead cells, were occasionally seen in and 
around ghost cells and membrane fragments. Ghost cells often contained 
an electron dense structure that was similar to that seen in intact 
cells. Other spherical structures were observed in and around the 
flocculated protein (Figure 3A). Short sections of the outer envelope, 
characterized by a "C-shaped" appearance, curled inward on themselves 
forming small vesicles. In contrast, cytoplasmic membranes attached to 
Figure 3. Effect of physical and enzymatic treatments on turkey-
grown P_. multocida. A. Cells from frozen saaçles thawed to 4 C Cvaccine 
II). B. and C. Negative stained and thin sectioned preparations of 
vesicles formed after incubation of vaccine II with the LS. D. Thin 
section preparation of vesicles formed after Incubation of B and C above 
with the VRS (vaccine IV). The bar represents 0.5 urn. 
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each other forming elongated structures. Isolated masses of branched 
fibrillar material, thought to be turkey plasma fibrin, were also 
observed. 
Vesicles of various sizes and shapes formed after the thawed sus­
pension was incubated 3 hr in the LS (Figure 3B and 3C). In thin 
sections, these vesicles ranged in size from 0.05 um to 1.0 um. The 
large, flat or folded sheets of membrane corresponding to CM in the 
thawed suspension were not observed. In negative-stained preparations 
(Figure 3B), these vesicles were spherically shaped. 
In thin section preparations (Figure 3C), the vesicles had a 
trilaminar membranous structure. Many of these vesicles had another 
internal layer that appeared to have peeled away from the inside. 
Whether this layer was CM or a murein layer was difficult to ascertain. 
In the treatment for vaccine IV, where the viscosity of the LS-
treated lysate was reduced with the VRS, vesicles more homogenous in 
size, shape, and appearance were observed. These vesicles, ranging from 
0.1 um to 0.6 um in size, are shown in Figure 3D. After VRS treatment, 
the trilaminar membranous arrangement was retained, but the internal 
layer (as seen in Figure 3C) was not present. 
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DISCUSSION 
multoclda cells, shown by Figure lA and IB, possess a charac­
teristic multilaminar outer envelope and cytoplasmic membrane. This 
arrangement is consistent with the morphological structure described for 
most Gram-negative bacteria (3,4). 
Bacteriolysis of turkey-grown multocida after thawing from a 
frozen state made studies on the immunogenicity of mildly disrupted 
bacterial preparations possible (1). Complete solubilization of the 
lysate with LS and VRS was not achieved as evidenced by Figure 3D. 
Freeze-thawing together with LS-VRS treatment (vaccine IV) resulted in a 
suspension consisting entirely of small membranous vesicles. The 
appearance of these vesicles is characteristic of the appearance of 
vesicles from other bacteria grown in vitro and treated similarly 
(5,6,7). 
Earlier studies showed that filtered, freeze-thawed, VRS-treated 
lysates lost the ability to induce heterologous serotype protection (1). 
The vesicles shown in Figure 3D were of a size that might be retained by 
a 0.22 um filter. If the CPF were still membrane bound in the vesicles, 
a reduction in CPF activity by filtration would be a result. 
Rimler et al. (1) found that the CPF was loosely associated with 
the bacterial cell and could be removed sinçly by washing. As shown, 
large amounts of outer membranous material were observed on the surface 
of negative stained preparations of multocida from the plasma. 
Because no evidence of these blebs was observed in thin sections of 
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cells from the same preparation, the material was possibly removed by 
washing when the cells were processed for thin sectioning as suggested 
by Russell (8). If the CPF were membrane bound, a high proportion of 
these blebs would be removed by washing when the cell vaccine was prepared. 
The internal structures observed in turkey-grown 2» multocida 
closely resemble those described by Cota-Robles in magnesium starved 
cells oi: coli B (9). The electron dense areas (Figures 2B and 2C) 
and internal membranous structures (Figure 2D) are morphologically 
similar to the dense, polar, agranular regions and vesicles he described. 
Similar structures have been observed in coli (Dr. L. H. Arp, USDA-
NADC, Ames, Iowa, personal communication) and 2» multocida in infected 
turkey livers (K. A. Brogden, unpublished data). These structures have 
not been seen in multocida grown on laboratory media (10). As Cota-
Robles suggested with coli, multocida may produce these structures 
when grown under conditions of physiological stress. It is also possible 
that the environment of the infected host may influence the cellular 
structure by providing nutritional or growth conditions which result in 
morphological variation for 2» multocida. Environment can alter morpho­
logic as well as other cell characteristics (11). 
Bacteriolysis of turkey-grown £. multocida after freezing and 
thawing to 4°C is a characteristic not commonly observed with cells 
grown in vitro on laboratory mediums. Cell damage caused by freezing 
and thawing may be due to exposure of the organism to the increased 
lysozyme levels found in infected turkey plasma. Lysozyme is detectable 
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in bacteremia and endotoxemic turkey plasma but not in normal turkey 
plasma (12). In the turkey, exposure of the bacteria to plasma lysozyme 
and a decrease of available plasma divalent cations may provide a 
mechanism for the release of endotoxin vivo in the form of blebs from 
cells, similar to those shown in Figure IB. Endotoxin is released from 
gram-negative bacteria ^  vitro (without cell lysis) upon chelation of 
divalent cations with EDTA in the presence and absence of lysozyme. 
Lysozyme elevation (12) and hypocalcemia (13) may be host protective 
responses to bacteria and endotoxin, and a bacteremia and endotoxemia 
initiate these responses apparently creating a detrimental cycle to the 
bacteremia host. 
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SUMMARY 
The effects of differential centrifugation, density gradient 
centrifugation, freeze-thawing, and chemical lysis on the morphology of 
P. multocida from the blood of infected turkeys were examined by electron 
microscopy. No morphologic differences were seen between thin section 
preparations of P. multocida after differential or density gradient 
centrifugation. The internal ultrastructure of ^  vivo grown cells was 
different from that observed previously for 2» multocida grown vitro. 
Large membranous blebs were also observed on the surface of negative 
stained preparations of organisms from the plasma but not in thin sections 
of cells from the same preparation. Freeze-thawing of bacterial sus­
pensions in sucrose resulted in partial lysis revealing bacteria in 
different phases of degradation. Complete lysis (but not solubilization) 
was effected by treatment with EDTA, lysozyme, and Triton X-100. 
Centrifuged lysate pellets were thin sectioned or negative stained. 
Pellets consisted of vesicles, ranging in size from 0.05-1.0 ii,m, that 
had a characteristic trilaminar membranous appearance similar to those 
reported for other gram-negative bacteria grown ^  vitro and treated 
similarly. 
23 
REFERENCES 
1. Riinler RB, Rebers PA, Rhoades KR: Fowl cholera: Ctosa-
protection induced by Pasteurella multoclda separated from Infected 
turkey blood. Avian Dis 23:720-741, 1979. 
2. Brenner S, Home RW: A negative staining method for high 
resolution electron microscopy of viruses. Biochim Biophys Acta 34:103-
110, 1959. 
3. Depetris S : Ultrastructure of the cell wall of Escherichia 
coli and chemical nature of its constituent layers. Ultrastruct Res 
19:45-83, 1967. 
4. Glauert AM, Thornley MJ: The topography of the bacterial cell 
wall, in Clifton CE, Raffel S, Starr MP (ed): Annual Review of 
Microbiology. Palo Alto, Calif, Annual Reviews, Inc., 1969, pp 159-198. 
5. Schnaitman CA: Effect of ethylenediamine-tetraacetic acid, 
triton XlOO, and lysozyme on the morphology and chemical composition of 
isolated cell walls of Escherichia coll. J Bacterid 108:553-563, 1971. 
6. Smyth CJ, Siegel J, Salton MRJ, Owen P: Immunochemical analysis 
of inner and outer membranes of Escherichia coli by crossed Immuno­
electrophoresis. J Bacteriol 133:306-319, 1978. 
7. Yamato I, Anraku Y, Hirosawa K: Cytoplasmic membrane vesicles 
of Escherichia coli. I. A simple method for preparing the cytoplasmic 
and other membranes. J Biochem 77:705-718, 1975. 
8. Russell RRB: Free endotoxin - A review. Microbios Letters 
2:125-135, 1976. 
24 
9. Cota-Robles EH: Internal membranes in cells of Escherichia 
coli. J Ultrastruct Res 16:626-639, 1966. 
10. Brogden KA; Studies on Pasteurella multocida; Coiiq>arlson of 
typing systems and description of certain ultrastructural features. 
Thesis. Iowa State University, Ames, Iowa, 1977. 
11. Lacey BW: Non-genetic variation of surface antigens in 
Bordetella and other micro-organisms, in Meynell GG and Gooder H (ed); 
Microbial Reactions to Environment. London, Cambridge University Press, 
1961, pp 343-390. 
12. Rimler RB, Brown WE: Pasteurella multocida; Plasma lysozyme 
in bacteremic and lipopolysaccharide-exposed turkeys. J Infect Dis 
142:614-617, 1980. 
13. Skarnes RC, Rosen FS: Host-dependent detoxification of 
bacterial endotoxin, in Kadis S, Weinbaum G, Ajl SJ (ed): Microbial 
toxins. Vol 5. Bacterial endotoxins, New York, Academic Press, 1971, 
pp 151-165. 
25 
SECTION II. LYSATES OF TURKEY-GROWN PASTEURELLA MULTOCIDA; 
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INTRODUCTION 
An intrahost environment may influence capsulation (1), phenotypic 
expression of antigens (2), physical properties (2), and ultrastructural 
morphology^  of Pasteurella multocida. Also, an immunogen, termed 
cross-protection factor (CPF) because it induces heterologous serotype 
2 2 protection in turkeys (2,3), chickens, and mice, is produced by P_' 
multocida in response to the environmental conditions in which it is 
grown. The CPF is maintained or produced when 2» multocida is cultivated 
in vitro in a complex medium containing host tissue (4), grown in the 
host (2,3), or grown in embryonating eggs (5). CPF is not observed when 
2" multocida is grown on common laboratory medium (6,7). 
Other than its immunizing properties, little is known about the 
nature of the CPF. Beginning studies showed that it was resistant to 
physical treatments (i.e. freeze-thaw) and mild lytic procedures (2). 
2 Centrifugation and filtration (2) studies, as well as electron microscopic 
examination,^  suggested that the CPF may be membrane bound in the outer 
envelope of JP* multocida. The purpose of the study reported here was to 
define some of the physical properties of CPF from completely lysed, 
turkey-grown jP« multocida. 
S^ection I. Am J Vet Res (to be published). 
2 Rimler RB, Rhoades KR: Lysates of turkey-grown Pasteurella 
multocida; Protection against homologous and heterologous serotype 
challenge exposure. Am J Vet Res (in press). 
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MATERIALS AND METHODS 
Cultures. Encapsulated £. multoclda strains X-73 (serotype 1) and 
P-1059 (serotype 3) were the same as those used in previous studies 
Preparation of lysates. Bacteremia blood from turkeys experimentally 
exposed to strain P-1059 was collected as previously described (2). 
Pasteurella multoclda, in lots from individual turkeys, were separated 
from the blood by differential and density gradient centrifugation and 
frozen at -70°C as described previously.^  Frozen bacterial suspensions 
from 8 turkeys were thawed to 4°C, combined, and mixed thoroughly resulting 
in a bacterial suspension containing 4.90 x 10^  ^CFU/ml (Table 1). 
Enzymatic lysis of this suspension was done as described.^  Briefly, 3 
parts suspension was mixed with 1 part lytic solution (LS) that contained 
120 ug/ml egg white lysozyme (Worthington Biochemical Corp., Bedford, 
MA), 4.0 mM EDTA, 0.4% Triton X-100, and 400 ug/ml hyaluronidase (Worth­
ington Biochemical Corp., Bedford, MA) in 0.025 M Tris buffer (pH 7.0) 
and allowed to incubate for 4.5 hours at 4°C. After mixing, the suspension 
contained 3.67 X 10^  ^CFU/ml. The bacteria were Completely lysed after 
2 incubation as determined by electron microscopic analysis. The viscosity 
of the suspension was reduced by mixing 3 parts lysate with 1 part of a 
Rimler RB, Rhoades KR: Lysates of turkey-grown Pasteurella 
multocida; Protection against homologous and heterologous serotype 
challenge exposure. Am J Vet Res (in press). 
2 Section I. Am J Vet Res (to be published). 
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Table 1. Quantities of in vivo grown Pasteurella multocida 
harvested from turkeys 
Turkey No. CFU/ml 
Amount 
(ml) Total CPU 
85 9.0x10* 10.6 9.54x10^ ° 
97 5.51x10^ ° 16.5 9.09x10^ 1 
100-101 4.91x10^ ° 31.5 1.55x10^ 2 
102 6.1x10^ ° 31 1.89x10^  ^
104 5.54x10^ ° 11.7 6.48x10^ 1 
105-106 3.19x10^ ° 7.5 2.39x10^  ^
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viscosity reducing solution CVRS) that contained 100 ug/ml DNase (Sigma 
Chemical Co., St. Louis, MO), 400 ug/ml hyaluronidase (Worthington 
Biochemical Corp. , Bedford, MA), and 0.01 M MgCl^  in 0.025 M Tris buffer 
(pH 7.0) and incubated 3 hours at 4°C. A portion of the mixture was 
diluted with 0.025 M tris buffer (pH. 7.0) to give a suspension containing 
the equivalent of 2 X 10^  ^CFU/ml. This suspension was called the whole 
lysate. Formalin was added (0.3% v/v) to an aliquot of whole lysate, 
and it was diluted 1:4 with 0.3% formalinized Tris buffer (vaccine 1). 
Differential centrifugation of whole lysate. An aliquot of whole 
lysate was centrifuged for 1 hour at 38,500 SPM (100,000 X g) in a 
Beckman Ti50 rotor at 4°C. The supernatant was removed, formalin was 
added (0.3% v/v), and the volume was adjusted to 4 times that of uncentri-
fuged whole lysate (vaccine 2). The pellet was resuspended in 0.025 M 
Tris - 1.0 mM EDTA buffer equivalent in volume to the supernatant removed, 
formalin was added (0.3% v/v), and the volume was adjusted to 4 times 
that of uncentrifuged whole lysate (vaccine 3). 
Density gradient centrifugation of whole lysate. Density gradient 
centrifugation of whole lysate was done by the method of Greenawalt (8). 
Four milliliters of whole lysate per tube were layered over 27.5 ml of 
discontinuous sucrose gradient. The gradient contained 5 ml each of 15, 
20, 30, 40, and 50% (w/v) sucrose over 4.5 ml of a 60% (w/v) sucrose 
cushion. The tubes were centrifuged for 16 hours at 25,000 RPM (53,500 
X g) in a Spinco SW 25.1 rotor. Three equal fractions per tube were 
collected by pumping with a peristalic pump from the bottom of each tube 
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by the method of Caul et al. (9). Like fractions from tubes were 
pooled, formalin was added (0.3% v/v) and the pooled fractions were 
adjusted in volume to 4 times that of uncentrifuged whole lysate. 
Vaccines 4, 5, and 6 were from roughly the top 15 to 20%, middle 30 to 
40%, and bottom 50 to 60% gradients, respectively. 
Heat inactivatlon. An aliquot of whole lysate was heated for 1 
hour in a 56°C waterbath. After incubation, formalin was added (0.3% 
v/v) and the lysate was diluted 1:4 as described above (vaccine 7). 
Enzymatic digestion. 4.65 mg of trypsin (Worthington Biochemical 
Corp., Bedford, MA) was added to 10 ml of lysate. The pH was adjusted 
from pH 7.0 to 7.5 with 0.1 N NaOH and the lysate was incubated for 3 
hours in a 37°C waterbath. After incubation, 5.10 mg of soybean tirypsin 
inhibitor (Worthington Biochemical Corp., Bedford, MA) was added and the 
pH was readjusted to 7.0. Formalin was added (0.3% v/v)) and the volume 
was adjusted to 4 times that of the original whole lysate (vaccine 8). 
An additional 10 ml of lysate was adjusted to pH 2.5 with 0.1 N 
HCl, 4.65 mg of pepsin was added, and the suspension was incubated for 3 
hours in a 37°C waterbath. After incubation, the pH was readjusted to 
7.0, formalin was added (0.3% v/v), and the volume was adjusted as 
described above. 
All vaccines were checked for sterility on artificial media and in 
embryonating chicken eggs before use. 
SDS-PAGE. Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) was done in preformed 2 to 16% polyacrylamide gradient gels 
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(Pharmacia Fine Chemicals, Piscataway, NJ) by the method of Margolis 
(10) in 0.05M imidazole buffer (pH 7.0) containing 0.2% SDS. Samples 
were suspended in imidazole buffer that contained 1% SDS and 0.25% 2-
mercaptoethanol and heated in a boiling waterbath for 2 minutes. 
Electrophoresis was done at 100 v per slab for 3 hours. 
Chemical analysis. Protein concentrations were determined as 
described by Bradford using bovine serum albumin, fraction 5 as the 
standard (11)= This assay was compatible with most of the reagents used 
in this study. Carbohydrate was measured by the phenol-sulfurlc acid 
test with glucose as the standard (12). 2-keto-3-deoxyoctonate (KDO) 
concentrations were determined as described by Karkhanls et al. using 
KDO (Sigma Chemical Co., St. Louis, M)) as the standard (13). Due to 
residual nondialyzable carbohydrate contaminants in the sucrose used for 
density gradient centrifugation, total carbohydrate and KDO determina­
tions were not possible on those fractions. 
Electron microscopy. Flocculate material in the supernatant was 
removed by centrifugation for 1 hour at 38,500 RPM (100,000 x g) in a 
Beckman Ti50 rotor and processed for electron microscopy as previously 
described.^  
Vaccination and challenge. There is no assay for CPF other than 
immunogenic activity. Therefore, the efficacy of a treatment was tested 
by immunizing turkeys with the vaccines and challenging their immunity. 
S^ection I. Am J Vet Res (to be published). 
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Turkeys were housed as previously described (2) and vaccinated at 6 and 
9 weeks of age in the right breast muscle with 1.0 ml doses of vaccine. 
Prevaccination serums showed no detectable antibodies to JP. multocida by 
either gel diffusion precipitin tests or tube agglutination tests (14). 
Cross-immunity was challenged at 11 weeks of age by injecting 0.1 
ml of brain heart infusion broth containing encapsulated X-73 C 4,250 
CPU) into the right breast muscle. After challenge, the birds were 
observed daily for 2 weeks. 
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RESULTS 
Differential centrlBugation. When centrifuged at 100,000 % g, the 
whole lysate separated into a transparent supernatant and white, particu­
late pellet. The whole lysate, supernatant, and pellet SDS-PAGE patterns 
are shown in Figure 1. The whole lysate pattern consisted of at least 
25 bands throughout the gradient gel. The lytic treatment used to 
prepare the whole lysate released soluble material as seen by corresponding 
bands of the supernatant. However, the insoluble whole lysate material 
can be seen in the pellet patterns. Eighty-four percent (2.40 mg/ml) of 
the whole lysate protein was in the supernatant (Table 2) leaving 15% 
(0.42 mg/ml) in the pellet. Carbohydrate values for the supernatant and 
the pellet were 24.1% and 56.6% of the total, respectively. 
Production of cross-immunity by immunizing with the centrifugation 
products of the whole lysate can be seen in Table 3. The uncentrifuged 
whole lysate control produced good cross-production; only 1 death in the 
group. Statistically, there were no detectable differences (p = .51) in 
the proportional number of deaths between the lysate and either the 
supernatant or pellet. 
When formalin was added to the whole lysate for preparation of 
vaccine 1, an increase in turbidity was observed. After standing 
overnight, an aliquot was removed and examined by electron microscopy; 
small, trilaminar membranous vesicles surrounded by a precipitate were 
observed (Figure 2B). When formalin was added to the supernatant, an 
increase in turbidity was also observed. Electron microscopic examination 
Figure 1. SDS-PAGE pattern of turkey-grown Pasteurella multocida 
lysate after differential and density gradient centrlfugatlon showing 
the cytochrome marker (C), lysate (1), supernatant (2), pellet (3), top 
density gradient fraction (4), middle gradient fraction (5), bottom 
gradient fraction (6), and 56,000-280,000 molecular weight marker (M). 
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Table 2. Chemical composition of the fractions after differential 
centrifugatlon and sucrose density gradient centrifugatlon 
of turkey-grown 2» multocida lysate 
% of total lysate 
Fraction Protein Carbohydrate KDO 
Lysate 100^  100^  100^  
Centrifugation-100,000 xg 
Supernatant 84.2 24.1 16.9 
Pellet 14.7 56.6 83.4 
Sucrose density gradient 
Top layer 79.4 ND^  ND 
Middle Layer 12.8 ND ND 
Bottom layer 8.2 ND ND 
*Based on 2.85 mg/ml protein. 
4^20.6 ug/ml glucose. 
1^.51 ug/ml KDO. 
'Slot determined. 
Figure 2. Electron micrograph of A. The precipitate formed in 
formalinized supernatant, and B. Turkey-grown Pasteurella multocida 
lysate pellet showing the precipitate between the vesicles. The 
bar represents 0.5 urn. 
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of this material revealed a precipitate very similar to that observed 
between the vesicles in the formalinized lysate pellet (Figure 2A). The 
formation of this precipitate did not affect the ability of the lysate 
or supernatant to produce cross-immunity. 
Density gradient centrifugation. The whole lysate was fractionated 
by sucrose density gradient centrifugation. Bands were observed through­
out the gradient. Some particulate material pelleted below the 60% 
sucrose cushion. The sucrose solutions used to form the discontinuous 
gradient had a tendency to slur at the interface after 16 hours of 
centrifugation at 4°C. With the peristalic pump 3 precise equal fractions 
were collected. The bottom fraction, collected first, contained the 
particulate pellet, the 4.5 ml sucrose cushion, 5 ml of 50% sucrose, and 
2 ml of the 40% sucrose solution. This fraction contained only 8.2% 
(0.23 mg/ml) of the whole lysate protein and had an SDS-PAGE pattern 
similar to that of the lysate pellet from the differential centrifugation. 
At least 7 bands could be observed (Figure 1). The vaccine prepared 
from this fraction provided good cross-protection. 
The middle fraction consisted of the remaining 3 ml of the 40%, 5 
ml of the 30%, and 3 ml of the 20% sucrose layers. This fraction 
contained 12.8% (0.36 mg/ml) of the whole lysate protein. The SDS-PAGE 
pattern of the middle fraction consisted of 12 bands that corresponded 
to bands of both the supernatant and pellet of the differential centri­
fugation, but not readily to bands from the top and bottom gradient 
fractions. As shown in Table 3, this fraction contained enough CPF to 
provide only moderate cross-protection. 
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Table 3. Number of turkeys dying of fowl cholera after heterologous 
serotype challenge of immunity produced by ultracentrifugation 
and sucrose gradient fractions of turkey-grown Pasteurella 
multocida lysate 
Preparation No. dead/total 
Lysate 1/11 
Differential centrifugation 
Supernatant 3/10 
Pellet 3/10 
Density gradient centrifugation 
Top 0/10 
Middle 4/10 
Bottom 0/10 
Controls 10/10 
41 
The top gradient fraction contained 79.4% (2.26 mg/ml) of the whole 
lysate protein. SDS-Page pattern revealed that the top fraction contained 
soluble material that separated throughout the gel gradient. This 
fraction contained 20 bands with a pattern resembling the supernatant of 
the differential centrifugation. Like the bottom fraction, the vaccine 
from the top fraction produced absolute protection to cross-challenge 
with no detectable differences in the proportional number of deaths from 
the lysate. 
Heat inactivation. At 56°C, the whole lysate turned an opaque 
white. A precipitate formed upon standing. Heating at this temperature 
for 1 hour had no effect on cross-protection (Table 4). 
Enzymatic digestion. The effects of proteolytic enzyme treatment 
on the immunogenicity of whole lysate in turkeys are shown in Table 4. 
When adjusted to pH 2.5 for pepsin digestion, the lysate turned opaque 
white. After incubation with pepsin, the pH was readjusted to pH 7.0 
and the solution clarified. After pepsin digestion, the whole lysate 
had no cross-protecting capabilities. 
Trypsin digestion partially destroyed the CPF. Only half of the 
birds vaccinated with this suspension survived challenge exposure. 
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Table 4. Number of turkeys 
serotype challenge 
heat treated lysate 
cjlying of fowl cholera after heterologous 
of Immunity produced by enzymatic and 
Treatment No. dead/total 
Heat 56°C, 1 hr 0/10 
Trypsin 5/10 
Pepsin 10/10 
Controls 10/10 
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DISCUSSION 
CPF appears to be dispersed In the soluble and insoluble portions 
of a complete lysate of 2- multocida because immunogenic activity was 
observed in both the supernatant and pellet of the differential centri-
fugation. CPF activity in the supernatant is in a soluble form while 
CP F in the pellet is membrane bound in vesicles as described previously.^  
The supernatant collected from formalinized whole lysate did not 
induce protection against the homologous and heterologous strain of 2" 
multocida in a previous study; all of the immunizing activity was found 
2 in the pellet. This pellet consisted of membranous vesicles surrounded 
by a precipitate similar to that seen in Figure 2B. In the present 
study, protection against the heterologous strain of 2» multocida was 
induced by both the supernatant and pellet when formalin was not added 
to the whole lysate. A precipitate, devoid of vesicles or membrane 
fragments, formed when formalin was added to the supernatant of unforma-
linized whole lysate (Figure 2A). Formalin markedly changes the prop­
erties of proteins (15). Here, formalin did not destroy CPF activity, 
it only reduced CPF solubility. Formalin precipitation may be a method 
to aid in the elution of CPF from turkey-grown 2» multocida provided it 
does not mask or destroy essential components. The CPF activity of this 
precipitate has not yet been examined. 
S^ection I. Am J Vet Res (to be published). 
2 
Rimler RB, Rhoades KR: Lysates of turkey-grown Pasteurella 
multocida; Protection against homologous and heterologous serotype 
challenge exposure. Am J Vet Res (in press). 
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Protein determinations and SDS-PAGE revealed that the procedure 
used to prepare the lysate released most of the cell protein into 
solution; 84% of the total lysate protein was in the supernatant. Based 
upon values calculated for a typical gram-negative bacterium, 80% of 
bacterial protein should be soluble with 7. 5% of protein remaining bound 
structurally in the cell walls and membrane (16). These approximations 
are applicable to our data and can be assumed to account for the protein 
distribution seen in our fractions. 
CPF activity in both the soluble and pelleted portions of the 
lysate might be assumed to be due to incomplete solubilization of membranes 
by the preparative procedure. It seems more likely that soluble CPF 
tends to aggregate or associate with other components resulting in 
activity in both the differential supernatant and pellet. Also, CPF may 
be more than one factor. 
In density gradient centrifugation, CPF was found in the top and 
bottom fractions. The top and bottom fractions provided protection 
equivalent to that of the whole lysate. The middle fraction contained 
only enough CPF to protect about half the birds. Although the bottom 
gradient fraction and the differential centrifugation pellet had a 
disproportionately small amount of protein when compared with the 
soluble portion of the whole lysate, they had an immunizing capacity 
equivalent to the whole lysate. 
The immunogenic activity of CPF was greatly reduced after trypsin 
treatment and completely abolished after pepsin treatment. CPF activity 
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was not affected by heat at 56°C for 1 hour. Freeze-thaw, DNase, 
hyaluronidase, lysozyme, Triton X-100, and formalin were used In the 
preparation procedures. These treatments do not affect CPF activity.^  
For these reasons, the 2» multoclda CPF seems to be protelnaceous. 
Studies on ^  vivo grown 2- multoclda (hemorrhagic septicemia 
serotypes 6:B, H:B, and 6:E) from cattle have been described by Bain 
(17). Those 2» multoclda were reported to produce homologous and cross-
Immunity in mice. Bain found that his cross-protective antigen was 
susceptible to papain and moderately susceptible to trypsin. His cross-
protective immunogen was also destroyed after 30 minutes at 100°C and 
120 minutes at 121°C. He believed the immunogen to be protein. Our 
findings are very similar. 
If there is only one CPF and it is found in both soluble and 
insoluble forms, then solubilization of the vesicle membranes with con­
ventional solubilizers should be considered for maximum recovery of CPF 
from turkey-grown 2* multoclda. However, if there are more than one 
CPF, then the immunizing ability of solubilized membrane fractions would 
have to be examined independently from and together with components from 
the supernatant. 
R^imler RB, Rhoades KR: Lysates of turkey-grown Pasteurella 
multoclda; Protection against homologous and heterologous serotype 
challenge exposure. Am J Vet Res (in press). 
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SUMMARY 
Various treatments on the lysate of turkey-grown Pasteurella 
multocida were performed to determine the nature of the cross-protection 
factor (CPF), No cross-protection was produced with pepsin treated 
lysates. Moderate cross-protection was produced with trypsin treated 
lysates and cross-protection was unaffected by heating the lysate at 
56°C for 1 hour. When the lysate was centrlfuged for 1 hour at 100,000 
X g, CPF was found In both the supernatant and pellet fractions indicating 
that the CPF was polydispersed. After sucrose density gradient centrl-
fugatlon, more CPF was found in the top 15 to 20% and bottom 50 to 60% 
bands than in the middle 30 to 40% band. The lytic treatment released 
84.2% of the cell protein into solution. The Insoluble material in the 
100,000 X g pellet contained 14.7% of the total protein and the 50 to 
60% sucrose band contained 8.2% of the total protein. Although these 
fractions had a disproportionately small amount of protein, they had CPF 
equal in immunizing capacity to the whole lysate and soluble portions of 
the whole lysate. 
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SECTION III. LYSATES OF TURKEY-GROWN PASTEURELLA MULTOCIDA; 
THE EFFECTS OF SOLUBILIZING AGENTS ON THE IMMUNOLOGIC PROPERTIES 
OF MEMBRANE VESICLES 
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INTRODUCTION 
Previous studies on turkey-grown Pasteurella multocida showed that 
enzymatically produced lysates contained an immunogen that provided 
heterologous serotype protection (1). This immunogen, termed cross-
protection factor (CPF), was found in both the supernatant and pellet 
after centrifugation at 100,000 x g for 1 hour^ . Electron microscopic 
2 
examination of the pellet fraction revealed small membranous vesicles. 
Although this pellet contained a dis prop ort ionally small amount of 
protein in relation to the supernatant, it had CPF equal in immunizing 
capacity to the supernate and to the uncentrifuged whole lysate. 
Therefore, solubilization of these pelleted membranes should be con­
sidered for maximum recovery of CPF from turkey-grown Pasteurella 
multocida. 
The effects of various solubilizing agents on eucaryotic and pro-
caryotic cell membranes and their application to the isolation of 
biologically active compounds have been reviewed (2,3,4), These agents 
have been listed according to their mechanisms of action on membranes. 
The list includes agents that disrupt the electrostatic conditions of 
the membrane, chaotropic agents, aprotic and organic solvents, and ionic 
and non-ionic detergents. The purpose of this study was to examine and 
compare the effects of membrane solubilizing agents, representing the 
S^ection II. Am J Vet Res (to be published). 
2 Section I. Am J Vet Res (to be published). 
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groups described above, on lysate pellets containing membranous vesicles 
from turkey-grown Pasteurella multoclda in an effort to release the CPF 
into solution in an Immunologically active form. 
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MATERIALS AND METHODS 
Bacterial strains. Encapsulated Pasteurella loultoclda strains X-73 
(serotype 1) and P-1059 (serotype 3) were the same strains as those of 
1 2 previous studies. ' 
Lysates from broth-grown cells. Because turkey-grown P. multoclda 
are difficult to obtain, initial studies were done on the effects of a 
solubilizing agent on membranes from broth-grown cells. 
2» multoclda strain P-1059 were grown in broth and prepared for lysis 
by two different methods. In the first method, organisms were grown 
statically for 3 hr at 37°C in 1 L of a modified pneumococcus medium (5). 
The cells were harvested by centrifugation at 9,150 x g for 45 mln, 
washed in 0.025 M Tris buffer (pH 7.0), resuspended in 20% sucrose (w/v) 
in Tris buffer, and frozen at -70°C. In the second method, 2» multoclda 
were prepared to simulate cells that are encountered in the host. This 
was done by growing the cells at 41°C for 3 hr in 12 L of modified 
pneumococcus medium in a new Brunswick fermenter (New Brunswick Sci. Co., 
Inc., New Brunswick, NJ). The culture was agitated at 200 RPM and sparged 
with 500 cc of air per mln. The culture was concentrated to 600 ml by 
3 tangential flow filtration and the bacterial cells were collected by 
centrifugation as before. The pellet was resuspended in Tris buffer and 
S^ection I. Am J Vet Res (to be published). 
2 Section II. Am J Vet Res (to be published). 
3 
Phillips M, Rimler RB, Rebers PA; Failure of rlbosomes from 
nonencapsulated Pasteurella multoclda to protect CF-1 mice. Am J Vet 
Res (in press). 
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treated with 1 luM ethylene-diamine-tetraacetic acid (EDTA) and 8 ug/ml 
lysozyme (Worthington Biochemical Corp., Freehold, NJ) at 41°C for 5 min. 
After treatment, an equal volume of 40% sucrose (w/v) in Tris buffer was 
added to the suspension, and it was frozen at -70°C. 
Samples were removed for electron microscopic analysis before 
addition of sucrose to either preparation of cells. 
Aliquots of each of the frozen preparations of broth-grown cells were 
thawed to 4°C and lysed exactly as described for turkey-grown multocida. 
Samples for electron microscopic analysis were removed after each step as 
2 previously described. Lysates from both broth-grown cell preparations 
3 
were centrifuged at 100,000 x g for 1 hr as described, and the pellets 
were resuspended in 0.025 M Tris buffer, pH 7.0, containing 1 mM EDTA, 
separated into lots and refrozen at -70°C. 
Lysates from turkey-grown cells. So that direct comparisons could 
be made between studies, the turkey-grown IP. multocida P-1059 cells and 
3 lysates used in this study were the same as those used previously. 
3 The whole lysate of turkey-grown cells was prepared as before, and 
contained the equivalent of 2x10^  ^CFU/ml; four times an immunizing dose 
needed to provide cross-protection. Whole lysate was then centrifuged 
for 1 hr at 100,000 x g as described previously and the supernatant was 
R^imler RB, Rhoades KR: Lysates of turkey-grown Pasteurella 
multocida; Protection against homologous and heterologous serotype 
challenge exposure. Am J Vet Res (in press). 
2 
Section I. Am J Vet Res (to be published). 
3 Section II. Am J Vet Res (to be published). 
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removed and saved. The pellet was resuspended in 0.025 M Tris-1 mM EDTÂ 
buffer and refrozen in lots at -70°C. 
Solubilization of membrane vesicles. Frozen aliquots of either 
broth-grown or turkey-grown P-1059 resuspended pellets were thawed to 4°C 
and solubilized as reported for the following agents: 0.1 N NaOH followed 
by glycine neutralization (6), 1.0 M potassium thiocyanate (KSCN) (7), 
0.5 M lithium diiodosalicylate (LIS) (8), 6 M guanidine HCl (9), 
n-butanol (10), 40% dimethyl sulfoxide (DMSG) (10), 3% Triton X-100 (11), 
and 4% sodium lauryl sarcosinate (SLS) (12). Pellets, resuspended in the 
0.025 M Tris-1 mM EDTA buffer (pH 7.0), were treated twice by a procedure 
at 4°C. 
After each treatment, insoluble material was removed by centrifugation 
at 100,00 X g for 1 hr. The solubilizing agents were removed by dialysis 
and aliquots from the soluble and insoluble material were saved for bio­
chemical analysis. 
Preparation of soluble vaccines. Vaccines, to detect CPF, were 
prepared from the turkey-grown solubilized material only (Figure 1). In 
this study, we assumed the CPF was homogeneous and was either in the 
supernatant S^  ^or pellet P^  ^of the whole lysate. Therefore, a remixture of 
the supernatant S^  with the treatment soluble supernatant could result 
in a final soluble vaccine preparation containing CPF equivalent to that 
9 in 5x10 CFU/ml. All vaccines were checked for sterility and toxicity 
before use. The toxicity of 6 solubilizing agents were examined in 6 and 
10 day old embryos. The solubilizing dose was diluted to a concentration 
Figure 1. Schematic of the method for the preparation of soluble 
vaccines from turkey-grown Pasteurella multoclda lysate. 
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PREPARATION OF SOLUBLE VACCINES FROM 
TURKEY-GROWN Pasteurella multocida 
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that would be found in the final vaccine if it was not removed by dialysis. 
SDS-PAGE. Sodium dodecyl sulfate polyacrylmlde gel electrophoresis 
(SDS-PAGE) was done in preformed 2-16% polyacrylamide gradient gels as 
previously described.^  
Chemical analysis. Protein and carbohydrate concentrations were 
determined as previously described.^  Three percent Triton X-100 and 4% 
SLS interfered with the determination of protein. Enough Triton X-100 
could be removed with amberlite XAD to determine the protein concentration 
in the sample (13). Protein determination was not possible for the SLS 
treated material. 2-keto-3-deoxyoctonate (KDO) concentrations were 
determined using KDO (Sigma Chemical Co., St. Louis, MO) as the standard 
(14). 
Electron microscopy. Electron microscopy was performed as previously 
2 described. 
Vaccination and challenge. Because there is no ixL vitro assay for 
CPF, immunogenic activity was the only way to measure the efficacy of a 
treatment. Mixed-sex, white broad-breasted turkeys were vaccinated at 6 
and 9 weeks of age, and immunity was cross-challenged at 11 weeks of age 
with 14,250 CFU of X-73 as previously reported.^  
S^ection II. Am J Vet Res (to be published). 
2 Section I. Am J Vet Res (to be published). 
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Table 1. Chemical composition of the pelleted 41°C broth-grown and 
turkey-grown Pasteurella multocida lysates after treatment 
with membrane solubilizers. 
Percent of Total Pellet Content 
Protein Carbohydrate KDO 
41°C broth-grown cells , 
lysate pellet 100.0® 100.0 100.0^  
NaOH-Glycine 54.8 7.9 ND 
KSCN 7.9 3.0 ND 
LIS 46.3 4.9 ND 
Guanidine HCl 95.8 4.4 ND 
Butanol 5.1 0.3 ND 
DMSO 1.7 0.8 ND 
Triton X-100 26.0 10.1 ND 
SLS - 15.8 ND 
Turkey-grown cells , _ 
Lysate pellet 100.0 100.0® 100.0 
NaOH-glycine 57.8 - ND 
KSCN 16.8 17.7 ND 
LIS 32.2 9.2 ND 
Guanidine HCl 41.0 14.2 ND 
Butanol 1.9 8.5 ND 
DMSO 12.6 12.8 ND 
Triton X-100 43.0 3.5 ND 
SLS - 14.8 ND® 
3^45.6 ug/ml protein. 
9^76.4 ug/ml carboyhdrate. 
^^ 9.94 ug/ml KDO. ( 
4^19 ug/ml protein. 
4^20.6 ug/ml carbohydrate. 
7^.51 ug/ml KDO. 
%one detected. 
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RESULTS 
37^ C Broth-grown cells. 37°C broth-cultures of 2- muitoclda P-1059 
appeared as typical gram-negative bacteria having a trilaminar plasma 
membrane and loose fitting, convoluted, outer envelope. Internal 
morphology consisted of dense areas of ribosomes surrounding the nucleic 
acid. No empty areas, polar dense areas, or internal membranes seen with 
turkey-grown P-1059 were observed. Cells did not lyse upon thawing, and 
membranous vesicles, similar to those in turkey-grown £. multocida 
lysates, were not produced after enzymatic lysis treatment. Therefore, 
the cells were not used for further studies. 
41°C Broth-grown cells. 41°C broth-cultures of 2» multocida P-1059, 
treated with lysozyme and EDTA to simulate conditions in plasma from 
turkeys having fowl cholera had external morphology similar to turkey-
grown 2" multocida when examined by electron microscopy. The appearance 
of the cells after this treatment can be seen in Figure 2A. Large amounts 
of membranous material, blebs, were observed on the surface of negative-
stained preparations. These blebs originated from the outer envelope. 
Cells after thawing to 4°C and enzymatically lysed had membranous vesicles 
(Figures 2B and 2C), similar to those in turkey-grown multocida 
lysates. These vesicles, spherically shaped, ranged in size from 0.1 to 
0.6 urn and had a characteristic trilaminar membranous structure. 
S^ection II. Am J Vet Res (to be published). 
Figure 2. Electron micrographs of 41°C broth-grown Pasteurella 
multoclda showing A. A negative-stained cell after lysozyme and EDTÂ 
treatment and B and C. Negative-stained and thin sectioned preparations 
of vesicles formed after enzymatic lysis of cells. The bar represents 
0. 5 um. 
m 
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Solubilization of membrane vesicles. Several techniques were used 
to solublllze vesicles from the 41°C broth-grown cells. Techniques 
successful in solubulizing the 41°C broth-grown cell vesicles were then 
used to solublllze membrane vesicles from turkey-grown cells in order to 
release the CPF. Although 41°C broth-grown cells were used primarily to 
examine the effects of lysozyme and EDTA on cell morphology and to 
provide a model for membrane solubilization, the opportunity existed to 
partially compare the biochemical determinations of the lysates and 
solubilized membrane fractions with those of turkey-grown ]P. multocida. 
When centrifuged at 100,000 x g the lysate from 41°C broth-grown 
cells separated into a supernatant containing 13.8% (0.06 ug/ml) protein 
and a particulate pellet containing 80.3% (0.35 mg/ml) of total protein. 
In thin section preparations (Figure 2C), vesicles in this pellet had a 
trilaminar membranous structure containing what appeared to be ribosomes 
attached internally. 
The lysate, supernatant, and pellet from 41°C broth-grown cells 
separated by SDS-PAGE are compared to the lysate, supernatant, and 
pellet from turkey-grown cells in Figure 3. Although the majority of the 
bands correspond, there are at least 3 that appear in the turkey-grown 
pasteurella lysate that are not in the 41°C broth-grown cell lysate. 
Most of the bands, in the 28,600-57,200 MW range, were also in the 
100,000 X g supernatant. 
The effects of the solubilizing agents on the 41^ C broth-grown cell 
lysate pellet are summarized in Table 1 for comparative purposes. 
Figure 3. SDS-PAGE pattern of Pasteurella multocida lysate after 
centrlfugation at 100,00 x g showing the cytochrome C marker (C); turkey-
grown lysate (1), supernatant (3), and pellet (5); 41°C broth-grown 
lysate (2), supernatant (4), and pellet (6); and molecular weight 
marker (M). 
57.200 
42.900 
28.600 
14.300 
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Solubilization of membrane vesicles turkey-grown lysates. The 
results of the solubllizlng agents on turkey-grown cell lysate are also 
summarized in Table 1. KDO was found in the pellet but not detected 
in any of the supematants after treatment. Solubilization of 
pellet with NaOH-glycine released the most protein (242.1 ug/ml) into 
supernatant S^ . Pg and separated by SDS-PAGE can be seen in Figure 
4. The pellet P^  had a pattern very similar to the lysate pellet P^  
differing in only 3 bands. The Sg supernatant contained at least 7 
bands. Although solubilization released over half of the P^  protein 
into solution, the vaccine did not cross-protect; nine of ten birds died 
(Table 2), 
Solubilization of pellet P^  with chaotropic agents released 16.8% 
(70.3 ug/ml) protein and 17.7% (23.7 ug/ml) carbohydrate from KSCN and 
32.2% (134.7 ug/ml) protein and 9.2% carbohydrate for LIS. Guanidine 
solublization released 41.0% (171.8 ug/ml) protein and 14.2% (19.0 
ug/ml) carbohydrate. There were slight differences in SDS-PAGE between 
the pellet P^  and P^  after the solubilizations. The vaccine after KSCN 
solubilization provided good cross-protection while vaccines prepared 
after LIS or guanidine solubilization produced a moderate cross-protection. 
Solubilization of pellet P^  with butanol and DMSO released small 
amounts of protein and carbohydrates. Butanol treatment released 1.9% 
(7.8 ug/ml) protein and 8.5% (11.4 ug/ml) carbohydrate while DMSO 
treatment released 12.6% (52.8 ug/ml) protein and 12.8% (17.2 ug/ml) 
carbohydrate. The SDS-PAGE patterns of treatment insoluble pellet Pg 
Figure 4. SDS-PAGE pattern of Pasteurella multoclda lysate pellet 
Pj^  showing the cytochrome C marker (C); turkey-grown lysate (1); super­
natant (2); pellet (3); pellet fractions after solubilization: S^  (4) 
and P_ (5) after NaOH-glycine, S„ (6) and P„ (7) after KSCN, S„ (8) and 
V (97 after LIS, S (10) and P„ (11) after'^ guanidine HCl, S_ fl2) and 
Pg (13) after butanol, S^  (14) and P» (15) after DMSO, S- (16) and P„ 
(17) after Triton X-100, and S^  (18) and P_ (19) after SLS; and molecular 
weight marker (M). 
I WW 
57,200 
42.900 
28,600 
14.300 
on 
GO 
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Table 2. Number of turkeys dying of fowl diolera after heterologous 
serotype challenge of immunity produced by solubilized 
turkey-grown JP. multocida lysate 
Solubilizing Agent No. Dead/Total 
Electrostatic disruptors 
NaOH-glycine 9/10 
Chaotropic Agents 
KSCN 1/10 
LIS 4/10 
Guanidine 4/10 
Aprotic and Organic Solvents 
Butanol 6/10 
DMSO 6/10 
Detergents 
Triton X-100 6/10 
Sarcosine 1/10 
Controls 10/10 
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were very similar to each other as well as to pellet (Figure 4). 
Vaccines prepared after solubilization poorly cross-protected; 6 of 10 
turkeys died. 
Detergents differed in their effects on pellet Triton X-100 
released an additional 43% (180 ug/ml) protein and 3.5% (4.7 ug/ml) 
carbohydrate while SLS released 14.8% (19.9 ug/ml) carbohydrate. Protein 
determinations in SLS treated fractions could not be made due to inter­
ference of the detergent with the test. The SDS-PAGE pattern of pellet Pg 
after Triton X-100 solubilization was Identical to pellet P^ . The SDS-
PAGE pattern of pellet P^  after SLS solubilization was unique with only 
12 bands present. A number of other bands were in the S^  supernatant 
indicating a fair release of protein. Vaccines prepared after the SLS 
solubilization produced good cross-protection while the vaccine prepared 
after Triton X-100 solubilization did not. 
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DISCUSSION 
Bacteria grown vivo are more permeable and are more sensitive to 
the physical isolation procedures used to separate them from host 
tissues (15). Cell morphology of broth-grown jP. multocida was similar 
to that of turkey-grown P^ . multocida when in vivo growth conditions were 
simulated 22.vitro by growth At 41°C, exposure to lysozyme, and reduction 
of available divalent cation. These treatments rendered the broth-grown 
cells susceptible to lysis and resulted in the formation of membranous 
blebs similar to those in turkey-grown 2» multocida lysates.^  
The internal morphology of 37°C and 41°C broth-grown cells was not 
like that reported for turkey-grown JP. multocida.^  Empty spaces, 
electron dense areas, and internal membranes were not observed in either 
the 37°C or 41°C broth-grown cells. The host environment influences 
ultrastructural morphology as previously proposed.^  
The formation of membranous vesicles from 41°C broth-grown cells 
provided the means to examine methods for membrane solubilization before 
working on turkey-grown 2- multocida. Information gained from these 
methods was used in the solubilization of turkey-grown lysate pellet P^ . 
Although morphologically similar, some biochemical differences were 
observed between the broth-grown and turkey-grown cell lysates. When 
the 41°C broth-grown cell lysate was centrifuged 100,000 x g, the 
supernatant contained 13.8% protein and the pellet contained 80.3% protein. 
^Section I. Am J Vet Res (to be published). 
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This is in contrast to the 84.2% and 14.7% protein reported in the 
turkey-grown cell lysate supernatant and pellet, respectively.^  The 
carbohydrate values between the lysates were very similar. The higher 
proportion of protein in the 41°C broth-grown cell lysate pellet was due 
to ribosomes attached to the membrane (Figure 2C). This was not observed 
2 in lysate pellets from turkey-grown jP. multocida. 
As shown in Table 1, the solubilizing agents generally extracted 
about the same proportion of protein from both the 41°C broth-grown and 
turkey-grown cell lysate pellets. Little carbohydrate (less than 15%) 
was present after solubilization, and KDO was not detected in any Sg 
supematants. 
In the present study, the supematatant was pooled with super­
natant Sg to form a soluble vaccine containing CPF equal to that found 
g 
in 5 X 10 CFU/ml whole lysate to determine if CPF was composed of more 
than 1 factor. At the time this study and the previous study^  were 
initiated, preliminary work had shown that the supernatant S^ , from 
formalinized lysates, had no homologous or heterologous immunizing 
3 
capacity. Therefore, any solubilized protein from the pellet might need 
to be in association with a component in the supernatant to produce 
S^ection II. Am J Vet Res (to be published). 
2 Section I. Am J Vet Res (to be published). 
3 Rimler RB Rhoades KR; Lysates of turkey-grown Pasteurella 
multocida; Protection against homologous and heterologous serotype 
challenge exposure. Am J Vet Res (in press). 
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cross-protection. In the previous study, supernatant from unforma-
linized lysates had an immunizing capacity equal to the pellet , but 
not quite as good as the whole lysate.^  
Each solubilizing agent acts on membranes differently. The NaOH-
glycine method was reported to modify the electrostatic conditions in the 
membrane (4) and was used to isolate an immunogen from vivo-grown 
Pasteurella pestis pelleted material (6). It was an effective solubilizer 
in this study but vaccines did not protect. 
Chaotropic agents disrupt surface hydrophobic bonds in membranes and 
promote the transfer of hydrophobic groups from an apolar environment to 
an aqueous one (2,4). Guanidine is a general protein solubilizer (4), 
and LIS is selective for glycoproteins (8). Moderate amounts of protein 
were released by each, and the immunizing capacity of the vaccines were 
no better than the supernatant by itself. 
Thiocynates are general membrane solubilizers that have been used 
to solubilize major outer membrane proteins in Neisseria gonorrhoeae (7). 
In this study, KSCN was an effective solubilizing agent and there were no 
detectable differences (p = 0.84) between the lysate and soluble KSCN 
vaccine. 
Organic and aprotic solvents can extract carbohydrate or protein 
from membranes depending upon extraction conditions (10,16). Kohl and 
Sandermann (10) found that solubilization of Escherichia coli membrane 
^Section II. Am J Vet Res (to be published). 
74 
vesicles with butanol and DMSO released only 2% and 1.5% of the total 
membrane respectively. We have observed similar results (Table 1). 
Detergents interact with both hydrophilic and lipophilic regions 
of proteins in a disruptive fashion (4). Non-ionic detergents, such as 
Triton X-100, have been repeatedly used for the isolation of biologically 
active molecules (4,11). The 0.2% Triton X-100 used in the lysate 
preparative procedure did not affect CPF activity (1), but 3% Triton 
X-100 did. Whether the biological activity of CPF was destroyed by a 
dissociation of pre-existing subunits by 3% Triton X-100 as described by 
Simons et al. (17), or destroyed by highly oxidizable contaminants in 
the Triton (18) is not known. 
Sodium;-lauryl-sarcosine, an ionic detergent, has been used to 
selectively solubilize cytoplasmic membrane of coli (12). Sarcosine 
solubilization, in the presence of Mg , was found to partially protect 
the membrane from complete dissolution. After SLS solubilization, 
vaccines in our study produced good cross protection. The MgCl^  added 
during lysis may have afforded the partial protection of membrane as 
described by Filip et al. (12), thus preventing complete solubilization 
and destruction of CPF. 
Soluble vaccines, after KSCN and LIS solubilization, cross-protected 
better than that reported for both the supernatant S^  and pellet P^ , and 
equal to the whole lysate.^  Other vaccines did not cross-protect as well 
as that reported for supernatant S^  and pellet P^  separately.^  In the 
^Section II. Am J Vet Res (to be published). 
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soluble vaccines, cross-protection was expected to be at least equal to 
that of supernatant or better resulting from an additive effect when 
or better resulting from an additive effect when was combined with 
Sg. Because supernatant alone cross-protected,^  why should the 
supernatant plus additional protein from pellet P^ , not cross-protect 
as well as was seen with KSCN and SLS vaccines. ]}n most studies, 
recombination of bacterial components has had an additive effect on 
biological activity (6,19,20). In this study, both an increase and 
decrease in cross-protection were observed when soluble conçonents were 
combined. This could be due to a number of things. In at least one 
vaccine, carry-over of the solubilizing agent must be considered. Since 
Triton X-100 is not dialyzable, it would have been in the final vaccine. 
At this concentration Triton X-100 might have disrupted the CPF destroy­
ing its immunogenicity. In other vaccine preparations, the solubilizing 
agent may have had no effect on releasing CPF from the pellet P^  since 
soluble vaccines protected as well as the supernatant separately. 
Although the NaOH-glycine and guanidine solubilizations released 
between 40-55% of the pellet P^  protein, cross-protection was poor. 
Immunosuppression due to this large amount of protein might be considered 
but it seems more likely that the turkeys immunologically responded to 
all the protein, but not preferentially to the CPF as they would if the 
membranes were intact. 
Section II. Am J Vet Res (to be published). 
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SUMMARY 
Pasteurella multoclda grown in broth at 41°C and then treated with 
lysozyme and EDTA had properties similar to multoclda grown in the 
turkey. The external morphology of cells was similar and small membranous 
vesicles were formed when broth-grown cells were frozen, thawed, and 
enzymatlcally lysed. Distinct chemical differences were observed between 
the 41°C broth-grown and turkey-grown cells when these lysates were 
examined by SDS-PAGE. The effects of membrane solubilizers on pelleted 
turkey-grown lysate were examined in an effort to release additional 
protein that may contain the cross-protection factor (CPF). Soluble 
vaccines prepared from the lysate supernatant and solubilized lysate 
pellet material produced varying degrees of cross-protection to a 
heterologous serotype challenge. Vaccines prepared from solutions 
containing the most protein solubilized from the pellet did not cross-
protect the best. Only two preparations, the KSCN and SLS soluble 
vaccines, had immunizing capacities equal to the whole lysate from 
turkey-grown multoclda. 
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SUMMARY AND DISCUSSION 
The research described in this dissertation was part of a current 
project at the National Animal Disease Center designed to develop a cross-
protection bacterin for the prevention of fowl cholera. This dissertation 
research defined some of the physical properties of the cross-protection 
factor in lysates of turkey-grown JP. multocida and developed methods to 
obtain a sub-cellular solution that produced significant cross-immunity. 
Vaccine preparations were examined by electron microscopy to deter­
mine whether the degree of solubilization and nature could be explained 
by a visual analysis. Electron microscopy proved to be a valuable tool 
for monitoring treatments of the bacterial cells. Therefore, a conplete 
study was done to examine the ultrastructure of turkey-grown 2» multocida 
before and after sequential treatments designed to solubillze CPF. 
The ultrastructure of turkey-grown multocida was different from 
the ultrastructure of broth-grown 2» multocida. Internal polar empty 
areas, polar electron dense areas, and nuclear associated membranous 
structures were seen in turkey-grown 2- multocida but not in broth-grown 
2* multocida. In addition, large membranous blebs were observed on the 
surface of cells taken from the plasma of Infected turkeys. These blebs 
were thought to be a host induced response of 2« multocida to the 
Increased concentrations of lysozyme and decreased concentrations of 
available magnesium or calcium ions in infected turkey blood. These 
blebs were not seen on broth-grown cells. However, when 2» multocida 
was grown in broth at 4l°C and treated with concentrations of lysozyme 
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and EDTA to simulate the growth conditions in the blood of infected 
turkeys, blebs were observed. These findings suggested that in the 
bacteremic turkey, exposure of 2» multocida to these conditions could 
be a mechanism for the release of endotoxin iA vivo. 
In contrast to broth-grown P. multocida, turkey-grown ]P. multocida 
were susceptible to freezing and thawing. Electron microscopic analysis 
of thawed samples revealed bacteria in different phases of degradation. 
Complete lysis, but not solubilization, was effected by treating these 
partially lysed suspensions with EDTA, lysozyme, hyaluronidase, DNase, 
and Triton X-100. The resulting lysate was found to contain small, 
0.05-1.0 urn, membranous vesicles. ]P. multocida grown at 41°C in broth 
and treated with lysozyme and EDTA had physical properties similar to 
turkey-grown ]P. multocida and were also susceptible to freezing and 
thawing. They formed small membranous vesicles when suspensions were 
treated as above. 37°C broth-grown cultures were not susceptible to 
treatment. This finding supported the conclusion that conditions in 
which 2" multocida is grown have an effect on the resulting cellular 
structure. 
Lysates prepared from the 41°C broth-grown and turkey-grown cells 
were chemically distinct. When lysates were centrifuged, variations 
among the protein concentrations in each of the supernatants and pellets 
were observed. Differences in the lysates were also seen after SDS-PAGE, 
These findings suggested that the growth conditions influence the bio­
chemical composition of multocida. This biochemical difference may 
directly relate to the immunogenic differences between ^  vivo and in 
vitro grown multocida. 
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Proteolytic enzyme and heat treatments of turkey-grown P. multoclda 
lysates were done to determine If CPF might be heat labile protein. No 
cross-protection was produced with pepsin treated lysates. Moderate 
cross-protection was produced with trypsin treated lysates and cross-
protection was unaffected by heating the lysate at 56°C for 1 hour. 
Since the immunogenic activity of CPF was greatly reduced by proteolytic 
enzyme treatment and was not affected by mild heat, the CPF of turkey-
grown 2" multoclda appears to be a heat-sitable protein. 
Previous work on the antigenic components of 2» multoclda has 
centered on the polysaccharide antigens (i.e. llpopolysaccharide and 
capsular polysaccharide) as the active Immunizing components. While 
these antigens have been shown to induce a homologous serotype Immunity, 
they have not been shown to produce a heterologous serotype immunity. 
The finding that the CPF may be protein presents the opportunity to 
apply techniques of protein and membrane biochemistry to Pasteurellae 
research which may eventually lead to the isolation, purification, and 
characterization of CPF. 
When turkey-grown P. multoclda lysate was centrlfuged, CPF was 
found in both the supernatant and pellet. After sucrose density centrl-
fugation, more CPF was found in the top and bottom fractions than in the 
middle fraction. Protein determinations showed that most of the 
protein was released Into solution during the lytic treatment. Because 
the pellet and bottom gradient fraction had a disproportionate amount of 
protein and CPF equal in immunizing capacity to the whole lysate, CPF is 
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thought to be more immunogenic when membrane bound or in precipitated 
aggregates. It is also possible that CPF is a complex of more than one 
factor. This might account for the slight difference in immunogenlcity 
between the supernatant and pellet fractions and the whole lysate. 
Attempts were made to solubilize CPF protein from insoluble lysate 
material. Conventional membrane solubllizers were examined initially on 
broth-grown lysate pellets because of the difficulty of acquiring large 
quantities of turkey-grown cells. The solubilizing techniques developed 
with the broth-grown lysate pellets were applied to turkey-grown lysate 
pellets. Soluble vaccines prepared from the initial lysate supernatant 
in combination with the solubilized lysate pellet material produced 
various degrees of cross-protection against a heterologous serotype 
challenge. Only the KSCN and SLS soluble vaccines had immunizing 
capacity equal to the whole lysate. Other soluble vaccines (i.e. 
NaOH-glycine, butanol, DMSO, and Triton X-100) were not as immunogenic. 
Because most of the protein was solubilized from NaOH-glycine, guanidine, 
and Triton X-100 treated pellets, an additive immunologic effect should 
have occurred. In fact, solubilization of additional protein caused a 
reduction in immunity, worse than the individual components themselves. 
Numerous proteins solubilized from the membrane pellet might have pre­
sented different antigens to the turkey in such a way that the response 
to CPF was not preferential. 
Cross-protection factor, from turkey-grown 2» multocida, is an 
antigen that turkeys contend with during an infection. The CPF may be 
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the most Important Immunogen; providing immunity most like that seen 
when animals have survived an infection or when animals have been imr-
munized with live attenuated vaccines. The turkey response to lysates 
may aid in the isolation and identification of CPF and CPF properties 
may give clues concerning the immunity to 2» multocida under these con­
ditions. The findings in this study have provided information which 
will be essential to the isolation and purification of CPF. 
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